Protalix BioTherapeutics (PLX) Fails to deliver data

Key failure to deliver metrics for Protalix BioTherapeutics :

• Last SEC data release: 2024-12-13
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: £0.11 M
• Last year FTD volume: £0.11 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Protalix BioTherapeutics (PLX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Protalix BioTherapeutics (PLX) - since 2019

Protalix BioTherapeutics (PLX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amicus Therapeutics FOLD	£0.57 M	£6.32 M	🇺🇸 USA
Neurocrine Biosciences NBIX	£6.53 M	£25.47 M	🇺🇸 USA
Pfizer PFE	£46.85 M	£0.35 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	£14.49 M	£40.95 M	🇮🇱 Israel